Serina Therapeutics, Inc. Cost of Revenue
Serina Therapeutics, Inc. (SER) reported Cost of Revenue of $40.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-22.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2024-03-22
- Serina Therapeutics, Inc. cost of revenue for the quarter ending 2023-12-31 was $1.00K, a 0.00% change year-over-year.
- Serina Therapeutics, Inc. cost of revenue for the quarter ending 2023-09-30 was $33.00K, a 560.00% increase year-over-year.
- Serina Therapeutics, Inc. cost of revenue for the quarter ending 2023-06-30 was $5.00K, a 16.67% decline year-over-year.
- Serina Therapeutics, Inc. cost of revenue for the quarter ending 2023-03-31 was $1.00K, a 0.00% change year-over-year.
- Serina Therapeutics, Inc. cost of revenue for fiscal 2023 was $40.00K, a 207.69% increase from fiscal 2022.
- Serina Therapeutics, Inc. cost of revenue for fiscal 2022 was $13.00K, a 31.58% decline from fiscal 2021.
- Serina Therapeutics, Inc. cost of revenue for fiscal 2021 was $19.00K, a 26.92% decline from fiscal 2020.
- Serina Therapeutics, Inc. cost of revenue for fiscal 2020 was $26.00K, a 89.34% decline from fiscal 2019.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed | Cost of Revenue 12 month | Cost of Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $34.00K derived: sum of 2 quarters · filed 2024-03-22 | $39.00K derived: sum of 3 quarters · filed 2024-03-22 | $40.00K 10-K · filed 2024-03-22 | ||||
| 2023-09-30 | $33.00K 10-Q · filed 2023-11-14 | $38.00K derived: sum of 2 quarters · filed 2023-11-14 | $39.00K 10-Q · filed 2023-11-14 | $40.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-06-30 | $5.00K 10-Q · filed 2023-08-14 | $6.00K 10-Q · filed 2023-08-14 | $7.00K derived: sum of 3 quarters · filed 2024-03-22 | $12.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2023-03-31 | $1.00K 10-Q · filed 2023-05-12 | $2.00K derived: sum of 2 quarters · filed 2024-03-22 | $7.00K derived: sum of 3 quarters · filed 2024-03-22 | $13.00K derived: sum of 4 quarters · filed 2024-03-22 | ||||
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $6.00K derived: sum of 2 quarters · filed 2024-03-22 | $12.00K derived: sum of 3 quarters · filed 2024-03-22 | $13.00K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $5.00K 10-Q · filed 2023-11-14 | $11.00K derived: sum of 2 quarters · filed 2023-11-14 | $12.00K 10-Q · filed 2023-11-14 | $13.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $6.00K 10-Q · filed 2023-08-14 | $7.00K 10-Q · filed 2023-08-14 | $8.00K derived: sum of 3 quarters · filed 2023-08-14 | $10.00K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $1.00K 10-Q · filed 2023-05-12 | $2.00K derived: sum of 2 quarters · filed 2023-05-12 | $4.00K derived: sum of 3 quarters · filed 2023-05-12 | $17.00K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.00K derived: sum of 2 quarters · filed 2023-03-31 | $16.00K derived: sum of 3 quarters · filed 2023-03-31 | $19.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $2.00K 10-Q · filed 2022-11-10 | $15.00K derived: sum of 2 quarters · filed 2022-11-10 | $18.00K 10-Q · filed 2022-11-10 | $23.00K derived: sum of 4 quarters · filed 2022-11-10 | ||||
| 2021-06-30 | $13.00K 10-Q · filed 2022-08-12 | $16.00K 10-Q · filed 2022-08-12 | $21.00K derived: sum of 3 quarters · filed 2022-08-12 | $38.00K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-13 | $8.00K derived: sum of 2 quarters · filed 2022-05-13 | $25.00K derived: sum of 3 quarters · filed 2022-05-13 | $28.00K derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | $5.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $22.00K derived: sum of 2 quarters · filed 2022-03-29 | $25.00K derived: sum of 3 quarters · filed 2022-03-29 | $26.00K 10-K · filed 2022-03-29 | $158.00K 10-K · filed 2021-03-31 | |||
| 2020-09-30 | $17.00K 10-Q · filed 2021-11-12 | $50.00K 10-Q · filed 2020-11-16 | $20.00K derived: sum of 2 quarters · filed 2021-11-12 | $21.00K 10-Q · filed 2021-11-12 | $120.00K 10-Q · filed 2020-11-16 | $100.00K derived: sum of 4 quarters · filed 2021-11-12 | ||
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-13 | $36.00K 10-Q · filed 2020-08-14 | $4.00K 10-Q · filed 2021-08-13 | $70.00K 10-Q · filed 2020-08-14 | $83.00K derived: sum of 3 quarters · filed 2021-08-13 | $132.00K derived: sum of 4 quarters · filed 2021-08-13 | ||
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-17 | $34.00K 10-Q · filed 2020-05-14 | $80.00K derived: sum of 2 quarters · filed 2021-05-17 | $129.00K derived: sum of 3 quarters · filed 2021-05-17 | $182.00K derived: sum of 4 quarters · filed 2021-05-17 | |||
| 2019-12-31 | $79.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $128.00K derived: sum of 2 quarters · filed 2021-03-31 | $181.00K derived: sum of 3 quarters · filed 2021-03-31 | $244.00K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $49.00K 10-Q · filed 2020-11-16 | $102.00K derived: sum of 2 quarters · filed 2020-11-16 | $165.00K 10-Q · filed 2020-11-16 | $345.00K derived: sum of 4 quarters · filed 2020-11-16 | ||||
| 2019-06-30 | $53.00K 10-Q · filed 2020-08-14 | $116.00K 10-Q · filed 2020-08-14 | $296.00K derived: sum of 3 quarters · filed 2020-08-14 | $292.00K derived: sum of 4 quarters · filed 2020-08-14 | ||||
| 2019-03-31 | $63.00K 10-Q · filed 2020-05-14 | $243.00K derived: sum of 2 quarters · filed 2020-05-14 | $239.00K derived: sum of 3 quarters · filed 2020-05-14 | $318.00K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | $180.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2020-03-31 | $176.00K derived: sum of 2 quarters · filed 2020-03-31 | $255.00K derived: sum of 3 quarters · filed 2020-03-31 | $364.00K 10-K/A · filed 2020-03-31 | ||||
| 2018-09-30 | -$4.00K 10-Q · filed 2019-11-14 | $75.00K derived: sum of 2 quarters · filed 2019-11-14 | $184.00K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $79.00K 10-Q · filed 2019-08-14 | $188.00K 10-Q · filed 2019-08-14 | ||||||
| 2018-03-31 | $109.00K 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | $168.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |